特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
294620

世界の薬物乱用検査市場:産業分析、規模、シェア、成長率、動向、予測

Drugs of Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

出版日: | 発行: Transparency Market Research | ページ情報: 英文 196 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.49円
世界の薬物乱用検査市場:産業分析、規模、シェア、成長率、動向、予測
出版日: 2018年12月06日
発行: Transparency Market Research
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の薬物市場は、2015年の41億米ドルから、2024年末までに64億米ドルに達すると予測されています。市場は、2016年~2024年のCAGR (複合年間成長率) で、5.3%の成長が予測されています。

当レポートでは、世界の薬物乱用検査市場について調査分析し、産業分析、市場規模と予測、セグメント別の市場分析、地域別の市場分析、競合情勢など、体系的な情報を提供しています。

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 規制シナリオ
  • 市場力学
  • 市場収益予測
  • 市場見通し
  • ファイブフォース分析
  • バリューチェーン分析
  • 技術評価
  • 世界の需給シナリオ

第5章 世界の薬物乱用検査市場の分析と予測:製品タイプ別

  • イントロダクション
  • 製品比較マトリクス
  • 市場収益シェアと魅力分析:製品タイプ別
  • 市場規模予測:製品タイプ別

第6章 世界の薬物乱用検査市場の分析と予測:標本タイプ別

  • イントロダクション
  • 市場収益シェアと魅力分析:標本タイプ別
  • 市場規模予測:標本タイプ別

第7章 世界の薬物乱用検査市場の分析と予測:検査タイプ別

  • イントロダクション
  • 市場収益シェアと魅力分析:検査タイプ別
  • 市場規模予測:検査タイプ別

第8章 世界の薬物乱用検査市場の分析と予測:エンドユーザー別

  • イントロダクション
  • 市場収益シェアと魅力分析:エンドユーザー別
  • 市場規模予測:エンドユーザー別

第9章 世界の薬物乱用検査市場の分析と予測:地域別

  • 市場収益シェアと魅力分析:地域別
  • 市場規模予測:地域別

第10章 北米の薬物乱用検査市場の分析と予測

  • 市場概要
  • 市場価格シェア分析:製品タイプ別
  • 市場価格シェア分析:標本タイプ別
  • 市場価格シェア分析:検査タイプ別
  • 市場価格シェア分析:エンドユーザー別
  • 市場価格シェア分析:国別
  • 市場規模予測
  • 市場の魅力分析

第11章 ラテンアメリカの薬物乱用検査市場の分析と予測

  • 市場概要
  • 市場価格シェア分析:製品タイプ別
  • 市場価格シェア分析:標本タイプ別
  • 市場価格シェア分析:検査タイプ別
  • 市場価格シェア分析:エンドユーザー別
  • 市場価格シェア分析:国別
  • 市場規模予測
  • 市場の魅力分析

第12章 欧州の薬物乱用検査市場の分析と予測

  • 市場概要
  • 市場価格シェア分析:製品タイプ別
  • 市場価格シェア分析:標本タイプ別
  • 市場価格シェア分析:検査タイプ別
  • 市場価格シェア分析:エンドユーザー別
  • 市場価格シェア分析:国別
  • 市場規模予測
  • 市場の魅力分析

第13章 アジア太平洋地域の薬物乱用検査市場の分析と予測

  • 市場概要
  • 市場価格シェア分析:製品タイプ別
  • 市場価格シェア分析:標本タイプ別
  • 市場価格シェア分析:検査タイプ別
  • 市場価格シェア分析:エンドユーザー別
  • 市場価格シェア分析:国別
  • 市場規模予測
  • 市場の魅力分析

第14章 中東・アフリカの薬物乱用検査市場の分析と予測

  • 市場概要
  • 市場価格シェア分析:製品タイプ別
  • 市場価格シェア分析:標本タイプ別
  • 市場価格シェア分析:検査タイプ別
  • 市場価格シェア分析:エンドユーザー別
  • 市場価格シェア分析:国別
  • 市場規模予測
  • 市場の魅力分析

第15章 競合情勢

  • 市場企業
  • 市場シェア分析:国別
  • 企業プロファイル
    • F. Hoffmann La-Roche Ltd
    • Siemens Healthineers (Siemens AG)
    • Thermo Fisher Scientific, Inc.
    • Alere, Inc.
    • 島津製作所
    • Laboratory Corporation of America Holdings
    • Dragerwerk AG & Co. KGaA
    • Express Diagnostics International Inc.
図表

List of Tables

  • Table 1: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 2: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016-2026
  • Table 3: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016-2026
  • Table 4: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 5: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Region, 2016-2026
  • Table 6: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 7: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016-2026
  • Table 8: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016-2026
  • Table 9: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 10: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country, 2016-2026
  • Table 11: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 12: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016-2026
  • Table 13: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016-2026
  • Table 14: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 15: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 16: Asia Pacific Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 17: Asia Pacific Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016-2026
  • Table 18: Asia Pacific Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016-2026
  • Table 19: Asia Pacific Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 20: Asia Pacific Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 21: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 22: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016-2026
  • Table 23: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016-2026
  • Table 24: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 25: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 26: Middle East & Africa Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 27: Middle East & Africa Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Sample Type, 2016-2026
  • Table 28: Middle East & Africa Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Testing Type, 2016-2026
  • Table 29: Middle East & Africa Drug of Abuse Testing Market Size (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 30: Middle East & Africa Drug of Abuse Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016-2026

List of Figures

  • Figure 1: Global Drug of Abuse Testing Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 2: Global Drug of Abuse Testing Market Value Share, by Product Type (2017)
  • Figure 3: Global Drug of Abuse Testing Market Value Share, by Sample Type (2017)
  • Figure 4: Global Drug of Abuse Testing Market Value Share, by Testing Type (2017)
  • Figure 5: Global Drug of Abuse Testing Market Value Share, by End-user (2017)
  • Figure 6: Global Drug of Abuse Testing Market Value Share, by Region (2017)
  • Figure 7: Global Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2026
  • Figure 8: Global Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2018-2026
  • Figure 9: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Analyzers, 2016-2026
  • Figure 10: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Rapid Testing Devices, 2016-2026
  • Figure 11: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables, 2016-2026
  • Figure 12: Global Drugs of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2026
  • Figure 13: Global Drugs of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2018-2026
  • Figure 14: Global Drugs of Abuse Testing Sample Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Saliva 2016-2026
  • Figure 15: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Breath, 2016-2026
  • Figure 16: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urine, 2016-2026
  • Figure 17: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Blood, 2016-2026
  • Figure 18: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hair & Sweat 2016-2026
  • Figure 19: Global Drugs of Abuse Testing Market Value Share Analysis, by Testing Type, 2018 and 2026
  • Figure 20: Global Drugs of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2018-2026
  • Figure 21: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pain Management Testing, 2016-2026
  • Figure 22: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Criminal Justice Testing, 2016-2026
  • Figure 23: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Workplace Screening, 2016-2026
  • Figure 24: Global Drugs of Abuse Testing Market Value Share Analysis, by End Users, 2018 and 2026
  • Figure 25: Global Drugs of Abuse Testing Market Attractiveness Analysis, by End Users, 2018-2026
  • Figure 26: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2016-2026
  • Figure 27: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2016-2026
  • Figure 28: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by On-the-spot Testing, 2016-2026
  • Figure 29: Global Drugs of Abuse Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Forensic Laboratories, 2016-2026
  • Figure 30: Global Drugs of Abuse Testing Market Value Share Analysis, by Region, 2018 and 2026
  • Figure 31: Global Drugs of Abuse Testing Market Attractiveness Analysis, by Region, 2018-2026
  • Figure 32: North America Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2026
  • Figure 33: North America Drug of Abuse Testing Market Attractiveness Analysis, by Country, 2018-2026
  • Figure 34: North America Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2026
  • Figure 35: North America Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2026
  • Figure 36: North America Drug of abuse testing Market Value Share Analysis, by Testing Type, 2018 and 2026
  • Figure 37: North America Drug of abuse testing Market Value Share Analysis, by End-user, 2018 and 2026
  • Figure 38: North America Drug of Abuse Testing Market Value Share Analysis, by Country, 2018 and 2026
  • Figure 39: North America Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2018-2026
  • Figure 40: North America Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2018-2026
  • Figure 41: North America Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2018-2026
  • Figure 42: North America Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 43: Europe Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2026
  • Figure 44: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 45: Europe Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2026
  • Figure 46: Europe Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2026
  • Figure 47: Europe Drug of abuse testing Market Value Share Analysis, by Testing Type, 2018 and 2026
  • Figure 48: Europe Drug of abuse testing Market Value Share Analysis, by End-user, 2018 and 2026
  • Figure 49: Europe Drug of Abuse Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2026
  • Figure 50: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2018-2026
  • Figure 51: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2018-2026
  • Figure 52: Europe Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2018-2026
  • Figure 53: Europe Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 54: Asia Pacific Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2026
  • Figure 55: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 56: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2026
  • Figure 57: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2026
  • Figure 58: Asia Pacific Drug of abuse testing Market Value Share Analysis, by Testing Type, 2018 and 2026
  • Figure 59: Asia Pacific Drug of abuse testing Market Value Share Analysis, by End-user, 2018 and 2026
  • Figure 60: Asia Pacific Drug of Abuse Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2026
  • Figure 61: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2018-2026
  • Figure 62: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2018-2026
  • Figure 63: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2018-2026
  • Figure 64: Asia Pacific Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 65: Latin America Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2026
  • Figure 66: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 67: Latin America Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2026
  • Figure 68: Latin America Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2026
  • Figure 69: Latin America Drug of abuse testing Market Value Share Analysis, by Testing Type, 2018 and 2026
  • Figure 70: Latin America Drug of abuse testing Market Value Share Analysis, by End-user, 2018 and 2026
  • Figure 71: Latin America Drug of Abuse Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2026
  • Figure 72: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2018-2026
  • Figure 73: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2018-2026
  • Figure 74: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2018-2026
  • Figure 75: Latin America Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 76: Middle East & Africa Drug of Abuse Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2026
  • Figure 77: Middle East & Africa Drug of Abuse Testing Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 78: Middle East & Africa Drug of Abuse Testing Market Value Share Analysis, by Product Type, 2018 and 2026
  • Figure 79: Middle East & Africa Drug of Abuse Testing Market Value Share Analysis, by Sample Type, 2018 and 2026
  • Figure 80: Middle East & Africa Drug of abuse testing Market Value Share Analysis, by Testing Type, 2018 and 2026
  • Figure 81: Middle East & Africa Drug of abuse testing Market Value Share Analysis, by End-user, 2018 and 2026
  • Figure 82: Middle East & Africa Drug of Abuse Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2026
  • Figure 83: Middle East & Africa Drug of Abuse Testing Market Attractiveness Analysis, by Product Type, 2018-2026
  • Figure 84: Middle East & Africa Drug of Abuse Testing Market Attractiveness Analysis, by Sample Type, 2018-2026
  • Figure 85: Middle East & Africa Drug of Abuse Testing Market Attractiveness Analysis, by Testing Type, 2018-2026
  • Figure 86: Middle East & Africa Drug of Abuse Testing Market Attractiveness Analysis, by End-user, 2018-2026
  • Figure 87: Global Drugs of Abuse Testing Market, Company Share Analysis, 2018-2026
目次

Title:
Drugs of Abuse Testing Market (Products - Analyzers, Rapid Testing Devices, Consumables; Sample Type - Saliva, Breath, Urine, Blood, Hair and Sweat; Testing Type - Pain Management Testing, Criminal Justice Testing, Workplace Screening; End user - Forensic Laboratories, Diagnostic labs, On-the-spot Testing, Forensic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Global Drugs of Abuse Testing Market: Overview

This report analyzes the current and future scenario of the global drugs of abuse testing market. Increase in impact of drug and alcohol abuse on public health, rise in demand for drug abuse testing among private employers, and surge in abuse of prescription drugs are projected to be major drivers of the global market during the forecast period.

The global drugs of abuse testing market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product type, sample type, testing type, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market, and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global drugs of abuse testing market.

Global Drugs of Abuse Testing Market: Key Segments

Based on product type, the global drugs of abuse testing market has been segmented into analyzers, rapid testing devices, and consumables. The analyzers segment has been divided into immunoassay analyzers, chromatographic devices, and breath analyzers. The rapid testing devices segment has been bifurcated into urine testing devices and oral fluid testing devices. The consumables segment has been classified into fluid collection devices and others. In terms of sample type, the global market has been categorized into saliva, breath, urine, blood, and hair & sweat. Based on testing type, the global drugs of abuse testing market has been divided into pain management testing, criminal justice testing, and workplace screening. In terms of end-user, the global market has been categorized into hospitals, diagnostics laboratories, on-the-spot testing, and forensic laboratories.

Global Drugs of Abuse Testing Market: Regional Outlook

In terms of region, the global drugs of abuse testing market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report profiles major players in the global drugs of abuse testing market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key players operating in the global drugs of abuse testing market are Alere, Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Dragerwerk AG & Co. KGaA, Siemens Healthcare, Express Diagnostics International Inc., and Shimadzu Corporation.

The global drugs of abuse testing market has been segmented as below:

  • Global Drugs of Abuse Testing Market, by Product Type
  • Analyzers
  • Immunoassays Analyzers
  • Chromatographic Devices
  • Breath Analyzers
  • Rapid Testing Devices
  • Urine Testing Devices
  • Oral Fluid Testing Devices
  • Consumables
  • Fluid Collection Devices
  • Others
  • Global Drugs of Abuse Testing Market, by Sample Type
  • Saliva
  • Breath
  • Urine
  • Blood
  • Hair & Sweat
  • Global Drugs of Abuse Testing Market, by Testing Type
  • Pain Management Testing
  • Criminal Justice Testing
  • Workplace Screening
  • Global Drugs of Abuse Testing Market, by End-user
  • Hospitals
  • Diagnostics Laboratories
  • On-the-spot Testing
  • Forensic Laboratories
  • Global Drugs of Abuse Testing Market, by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • Italy
  • France
  • Spain
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Drugs of Abuse Testing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Market Overview
  • 4.3. Regulatory Scenario
  • 4.4. Market Dynamics
    • 4.4.1. Drivers
    • 4.4.2. Restraints
    • 4.4.3. Opportunities
    • 4.4.4. Trends
  • 4.5. Market Revenue Projections (US$ Mn)
  • 4.6. Market Outlook
  • 4.7. Porter's Five Forces Analysis
  • 4.8. Value Chain Analysis
  • 4.9. Technology Assessment
  • 4.10. Global Demand and Supply Scenario

5. Global Drugs of Abuse Testing Market Analysis and Forecast, by Product Type

  • 5.1. Introduction
  • 5.2. Product Comparison Matrix
  • 5.3. Market Revenue Share (%) and Attractiveness Analysis, by Product Type
  • 5.4. Market Size (US$ Mn) Forecast, by Product Type
    • 5.4.1. Analyzers
      • 5.4.1.1. Immunoassay Analyzers
      • 5.4.1.2. Chromatographic Devices
      • 5.4.1.3. Breath Analyzers
    • 5.4.2. Rapid Testing Devices
      • 5.4.2.1. Urine Testing Devices
      • 5.4.2.2. Oral Fluid Testing Devices
    • 5.4.3. Consumables
      • 5.4.3.1. Fluid Collection Devices
      • 5.4.3.2. Others

6. Global Drugs of Abuse Testing Market Analysis and Forecast, by Sample Type

  • 6.1. Introduction
  • 6.2. Market Revenue Share (%) and Attractiveness Analysis, by Sample Type
  • 6.3. Market Size (US$ Mn) Forecast, by Sample Type
    • 6.3.1. Saliva
    • 6.3.2. Breath
    • 6.3.3. Urine
    • 6.3.4. Blood
    • 6.3.5. Hair & Sweat

7. Global Drugs of Abuse Testing Market Analysis and Forecast, by Testing Type

  • 7.1. Introduction
  • 7.2. Market Revenue Share (%) and Attractiveness Analysis, by Testing Type
  • 7.3. Market Size (US$ Mn) Forecast, by Testing Type
    • 7.3.1. Pain Management Testing
    • 7.3.2. Criminal Justice Testing
    • 7.3.3. Workplace Screening

8. Global Drugs of Abuse Testing Market Analysis and Forecast, by End-user

  • 8.1. Introduction
  • 8.2. Market Revenue Share (%) and Attractiveness Analysis, by End-user
  • 8.3. Market Size (US$ Mn) Forecast, by End-user
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostics Laboratories
    • 8.3.3. On-the-spot Testing
    • 8.3.4. Forensic Laboratories

9. Global Drugs of Abuse Testing Market Analysis and Forecast, by Region

  • 9.1. Market Revenue Share (%) and Attractiveness Analysis, by Region
  • 9.2. Market Size (US$ Mn) Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East and Africa

10. North America Drugs of Abuse Testing Market Analysis and Forecast

  • 10.1. Market Overview
    • 10.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2026
    • 10.1.2. Testing Market Attractiveness Analysis, by Country
  • 10.2. Market Value Share Analysis, by Product Type
    • 10.2.1. Analyzers
      • 10.2.1.1. Immunoassay Analyzers
      • 10.2.1.2. Chromatographic Devices
      • 10.2.1.3. Breath Analyzers
    • 10.2.2. Rapid Testing Devices
      • 10.2.2.1. Urine Testing Devices
      • 10.2.2.2. Oral Fluid Testing Devices
    • 10.2.3. Consumables
      • 10.2.3.1. Fluid Collection Devices
      • 10.2.3.2. Others
  • 10.3. Market Value Share Analysis, by Sample Type
    • 10.3.1. Saliva
    • 10.3.2. Breath
    • 10.3.3. Urine
    • 10.3.4. Blood
    • 10.3.5. Hair & Sweat
  • 10.4. Market Value Share Analysis, by Testing Type
    • 10.4.1. Pain Management
    • 10.4.2. Criminal Justice Testing
    • 10.4.3. Workplace Screening
  • 10.5. Market Value Share Analysis, by End-user
    • 10.5.1. Hospitals
    • 10.5.2. Diagnostics Laboratories
    • 10.5.3. On-The-Spot Testing
    • 10.5.4. Forensic Laboratories
  • 10.6. Market Value Share Analysis, by Country
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Size (US$ Mn) Forecast
    • 10.7.1. By Product Type
    • 10.7.2. By Sample Type
    • 10.7.3. By Testing Type
    • 10.7.4. By End-user
    • 10.7.5. By Country
  • 10.8. Market Attractiveness Analysis
    • 10.8.1. By Product Type
    • 10.8.2. By Sample Type
    • 10.8.3. By Testing Type
    • 10.8.4. By End-user
    • 10.8.5. By End-user

11. Europe Drugs of Abuse Testing Market Analysis and Forecast

  • 11.1. Market Overview
    • 11.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2026
    • 11.1.2. Testing Market Attractiveness Analysis, by Country/Sub-region
  • 11.2. Market Value Share Analysis, by Product Type
    • 11.2.1. Analyzers
      • 11.2.1.1. Immunoassay Analyzers
      • 11.2.1.2. Chromatographic Devices
      • 11.2.1.3. Breath Analyzers
    • 11.2.2. Rapid Testing Devices
      • 11.2.2.1. Urine Testing Devices
      • 11.2.2.2. Oral Fluid Testing Devices
    • 11.2.3. Consumables
      • 11.2.3.1. Fluid Collection Devices
      • 11.2.3.2. Others
  • 11.3. Market Value Share Analysis, by Sample Type
    • 11.3.1. Saliva
    • 11.3.2. Breath
    • 11.3.3. Urine
    • 11.3.4. Blood
    • 11.3.5. Hair & Sweat
  • 11.4. Market Value Share Analysis, by Testing Type
    • 11.4.1. Pain Management
    • 11.4.2. Criminal Justice Testing
    • 11.4.3. Workplace Screening
  • 11.5. Market Value Share Analysis, by End-user
    • 11.5.1. Hospitals
    • 11.5.2. Diagnostics Laboratories
    • 11.5.3. On-the-Spot Testing
    • 11.5.4. Forensic Laboratories
  • 11.6. Market Value Share Analysis, by Country/Sub-region
    • 11.6.1. U.K.
    • 11.6.2. France
    • 11.6.3. Germany
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Russia
    • 11.6.7. Rest of Europe
  • 11.7. Market Size (US$ Mn) Forecast
    • 11.7.1. By Product Type
    • 11.7.2. By Sample Type
    • 11.7.3. By Testing Type
    • 11.7.4. By End-user
    • 11.7.5. By Country/Sub-region
  • 11.8. Market Attractiveness Analysis
    • 11.8.1. By Product Type
    • 11.8.2. By Sample Type
    • 11.8.3. By Testing Type
    • 11.8.4. By End-user

12. Asia Pacific Drugs of Abuse Testing Market Analysis and Forecast

  • 12.1. Market Overview
    • 12.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2026
    • 12.1.2. Testing Market Attractiveness Analysis, by Country/Sub-region
  • 12.2. Market Value Share Analysis, by Product Type
    • 12.2.1. Analyzers
      • 12.2.1.1. Immunoassay Analyzers
      • 12.2.1.2. Chromatographic Devices
      • 12.2.1.3. Breath Analyzers
    • 12.2.2. Rapid Testing Devices
      • 12.2.2.1. Urine Testing Devices
      • 12.2.2.2. Oral Fluid Testing Devices
    • 12.2.3. Consumables
      • 12.2.3.1. Fluid Collection Devices
      • 12.2.3.2. Others
  • 12.3. Market Value Share Analysis, by Sample Type
    • 12.3.1. Saliva
    • 12.3.2. Breath
    • 12.3.3. Urine
    • 12.3.4. Blood
    • 12.3.5. Hair & Sweat
  • 12.4. Market Value Share Analysis, by Testing Type
    • 12.4.1. Pain Management
    • 12.4.2. Criminal Justice Testing
    • 12.4.3. Workplace Screening
  • 12.5. Market Value Share Analysis, by End-user
    • 12.5.1. Hospitals
    • 12.5.2. Diagnostics Laboratories
    • 12.5.3. On-the-Spot Testing
    • 12.5.4. Forensic Laboratories
  • 12.6. Market Value Share Analysis, by Country/Sub-region
    • 12.6.1. Japan
    • 12.6.2. China
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Size (US$ Mn) Forecast
    • 12.7.1. By Product Type
    • 12.7.2. By Sample Type
    • 12.7.3. By Testing Type
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Product Type
    • 12.8.2. By Sample Type
    • 12.8.3. By Testing Type
    • 12.8.4. By End-user

13. Latin America Drugs of Abuse Testing Market Analysis and Forecast

  • 13.1. Market Overview
    • 13.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2026
    • 13.1.2. Testing Market Attractiveness Analysis, by Country/Sub-region
  • 13.2. Market Value Share Analysis, by Product Type
    • 13.2.1. Analyzers
      • 13.2.1.1. Immunoassay Analyzers
      • 13.2.1.2. Chromatographic Devices
      • 13.2.1.3. Breath Analyzers
    • 13.2.2. Rapid Testing Devices
      • 13.2.2.1. Urine Testing Devices
      • 13.2.2.2. Oral Fluid Testing Devices
    • 13.2.3. Consumables
      • 13.2.3.1. Fluid Collection Devices
      • 13.2.3.2. Others
  • 13.3. Market Value Share Analysis, by Sample Type
    • 13.3.1. Saliva
    • 13.3.2. Breath
    • 13.3.3. Urine
    • 13.3.4. Blood
    • 13.3.5. Hair & Sweat
  • 13.4. Market Value Share Analysis, by Testing Type
    • 13.4.1. Pain Management
    • 13.4.2. Criminal Justice Testing
    • 13.4.3. Workplace Screening
  • 13.5. Market Value Share Analysis, by End-user
    • 13.5.1. Hospitals
    • 13.5.2. Diagnostics Laboratories
    • 13.5.3. On-the-Spot Testing
    • 13.5.4. Forensic Laboratories
  • 13.6. Market Value Share Analysis, by Country/Sub-region
    • 13.6.1. Mexico
    • 13.6.2. Brazil
    • 13.6.3. Rest of Latin America
  • 13.7. Market Size (US$ Mn) Forecast
    • 13.7.1. By Product Type
    • 13.7.2. By Sample Type
    • 13.7.3. By Testing Type
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Product Type
    • 13.8.2. By Sample Type
    • 13.8.3. By Testing Type

14. Middle East & Africa Drugs of Abuse Testing Market Analysis and Forecast

  • 14.1. Market Overview
    • 14.1.1. Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016-2026
    • 14.1.2. Testing Market Attractiveness Analysis, by Country/Sub-region
  • 14.2. Market Value Share Analysis, by Product Type
    • 14.2.1. Analyzers
      • 14.2.1.1. Immunoassay Analyzers
      • 14.2.1.2. Chromatographic Devices
      • 14.2.1.3. Breath Analyzers
    • 14.2.2. Rapid Testing Devices
      • 14.2.2.1. Urine Testing Devices
      • 14.2.2.2. Oral Fluid Testing Devices
    • 14.2.3. Consumables
      • 14.2.3.1. Fluid Collection Devices
      • 14.2.3.2. Others
  • 14.3. Market Value Share Analysis, by Sample Type
    • 14.3.1. Saliva
    • 14.3.2. Breath
    • 14.3.3. Urine
    • 14.3.4. Blood
    • 14.3.5. Hair & Sweat
  • 14.4. Market Value Share Analysis, by Testing Type
    • 14.4.1. Pain Management
    • 14.4.2. Criminal Justice Testing
    • 14.4.3. Workplace Screening
  • 14.5. Market Value Share Analysis, by End-user
    • 14.5.1. Hospitals
    • 14.5.2. Diagnostics Laboratories
    • 14.5.3. On-the-Spot Testing
    • 14.5.4. Forensic Laboratories
  • 14.6. Market Value Share Analysis, by Country/Sub-region
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Size (US$ Mn) Forecast
    • 14.7.1. By Product Type
    • 14.7.2. By Sample Type
    • 14.7.3. By Testing Type
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Product Type
    • 14.8.2. By Sample Type
    • 14.8.3. By Testing Type
    • 14.8.4. By End-user

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix
  • 15.2. Market Share Analysis, by Company (2017)
  • 15.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 15.3.1. F. Hoffmann-La Roche AG
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Siemens Healthineers (Siemens AG)
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Thermo Fisher Scientific, Inc.
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Abbott
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Shimadzu Corporation
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Laboratory Corporation of America Holdings
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Danaher
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Dragerwerk AG & Co. KGaA
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Express Diagnostics International, Inc.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.